Syntheses of silatranyl- and germatranyluridines

Organic Letters

Volumn 7, Issue 6, 2005, Pages 1165-1168

  Rink, Chad M ^a   Mauck, Matthew C ^a   Asif, Irfan ^a   Pitzer, Michael E ^b   Fenlon, Edward E ^b  

^a XAVIER UNIVERSITY   (United States)

^b FRANKLIN AND MARSHALL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEUTERIUM OXIDE; GERMANIUM DERIVATIVE; RHENIUM; RNA; SILATRANE DERIVATIVE; URIDINE DERIVATIVE; VANADIUM;

ARTICLE; ENERGY YIELD; HYDROLYSIS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PHASE TRANSITION; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; STRUCTURE ANALYSIS; SYNTHESIS; TECHNIQUE;

DEUTERIUM OXIDE; GERMANIUM; HALF-LIFE; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; ORGANOSILICON COMPOUNDS; RNA; URIDINE;

EID: 18244393748     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol050133v     Document Type: Article

References (42)

1. Bernhard, S. A.; Orgel, L. E. Science 1959, 130, 625-626.
2. Lolis, E.; Petsko, G. A. Annu. Rev. Biochem. 1990, 59, 597-630.
3. Gu, Z.; Drueckhammer, D. G.; Kurz, L.; Liu, K. Martin, D. P.; McDermott, A. Biochemistry 1999, 38, 8022-8031.
4. (a) Mader, M. M.; Bartlett, P. A. Chem. Rev. 1997, 97, 1281-1301.
5. (b) Schultz, P. G.; Yin, J.; Lerner, R. A. Angew. Chem. 2002, 41, 4427-4437.
6. Wulff, G. Chem. Rev. 2002, 102, 1-27.
7. Schramm, V. L. Acc. Chem. Res. 2003, 36, 588-596.
8. Lindquist, R. N.; Lynn, J. L., Jr.; Lienhard, G. E. J. Am. Chem. Soc. 1973, 95, 8762-8768.
9. Messmore, J. M.; Raines, R. T. J. Am. Chem. Soc. 2000, 122, 9911-9916.
10. (a) Borah, B.; Chen, C.; Egan, W.; Miller, M.; Wlodawer, A.; Cohen, J. S. Biochemistry 1985, 24, 2058-2067.
11. (b) Wladkowski, B. D.; Svensson, L. A.; Sjolin, L. Ladner, J. E.; Gilliland, G. L. J. Am. Chem. Soc. 1998, 120, 5488-5498.
12. Rupert, P. B.; Massey, A. P.; Sigurdsson, S. Th.; Ferre-D'Amare, A. R. Science 2002, 295, 1421-1424.
13. For reviews, see: (a) Scott, W. G. Q. Rev. Biophys. 1999, 32, 241-284. (b) Hammann, C.; Lilley, D. M. J. ChemBioChem 2002, 3, 690-700.
14. For reviews, see: (a) Scott, W. G. Q. Rev. Biophys. 1999, 32, 241-284. (b) Hammann, C.; Lilley, D. M. J. ChemBioChem 2002, 3, 690-700.
15. Scott, W. G. University of California at Santa Cruz, Santa Cruz, CA. Personal communication, 2004.
16. (a) Chen, Y. C. J.; Janda, K. D. J. Am. Chem. Soc. 1992, 114, 1488-1489.
17. (b) Wentworth, P., Jr.; Wiemann, T.; Janda, K. D. J. Am. Chem. Soc. 1996, 118, 12521-12527.
18. (c) Weiner, D. P.; Wiemann, T.; Wolfe, M. M.; Wentworth, P., Jr.; Janda, K. D. J. Am. Chem. Soc. 1997, 119, 4088-4089.
19. Crans, D. C.; Felty, R. A.; Miller, M. M. J. Am. Chem. Soc. 1991, 113, 265-269.
20. Ray, W. J., Jr.; Crans, D. C.; Zheng, J.; Burgner, J. W., H; Deng, H.; Mahroof-Tahir, M. J. Am. Chem. Soc. 1995, 117, 6015-6026.
21. Vanadium Compounds; Tracey, A. S., Crans, D. C., Eds.; ACS Symposium Series 711; American Chemical Society: Washington, DC, 1998.
22. Angus-Dunne, S. J.; Batchelor, R. J.; Tracey, A. S.; Einstein, F. W. B. J. Am. Chem. Soc. 1995, 117, 5292-5296.
23. (a) Sculimbrene, B. R.; Decanio, R. E.; Peterson, B. W.; Muntel, E. E.; Fenlon, E. E. Tetrahedron Lett. 2001, 42, 4979-4982.
24. (b) Black, C. A.; Ucci, J. W.; Vorpagel, J. S.; Mauck, M. C.; Fenlon, E. E. Bioorg. Med. Chem. Lett. 2002, 12, 3521-3523.
25. Verkade, J. G. Coord. Chem. Rev. 1994, 137, 233-295.
26. Silatranes are the prototypical atranes; for a review, see: Voronkov, M. G.; D'yakov, V. M.; Kirpichenko, S. V.: Silatranes. J. Organomet. Chem. 1982, 233, 1-147.
27. McGee, D. P. C.; Vaughn-Settle, A.; Vargeese, C.; Yansheng, Z. J. Org. Chem. 1996, 61, 781-785.
28. If unmethylated, N-3 is subsequently alkylated by ethylene oxide further into the synthesis (see Supporting Information). The N3-methyl is also believed to provide stability to all of the atranyl-nucleosides (1, 2, 7, and 8). This is due to the fact the 2′-nitrogen is a decent leaving group (it has a formal positive charge) and it is well-known that uridines with leaving groups positioned on the 2′-position are subject to anhydrouridine formation. See Supporting Information and the following reference: Yung, N. C.; Fox, J. J. J. Am. Chem. Soc. 1961, 83, 3060-3066.
29. Mironov, V. F.; Gar, T. K.; Khromova, N. Yu.; Frid, O. D. J. Gen. Chem. USSR (Engl. Transl.) 1986, 56, 566-568.
30. Asakura, J.; Robins, M. J.; Asaka, Y.; Kim, T. H. J. Ory. Chem. 1996, 61, 9026-9027.
31. (a) Bellama, J. M.; Nies, J. D.; Ben-Zvi, N. Magn. Reson. Chem. 1986, 24, 748-753.
32. (b) Tandura, S. N.; Voronkov, M. G., Alekseev, N. V. Top. Curr. Chem. 1986, 131, 99-189.
33. See Supporting Information for more details.
34. (a) Marino, P. P.; Schwalbe, H.; Griesinger, C. Acc. Chem. Res. 1999, 32, 614-623.
35. (b) Bondensgaard, K. Mollova, E. T.; Pardi, A. Biochemistry 2002, 41, 11532-11542.
36. C17 in the hammerhead ribozyme was previously replaced with 3-methyluridine and found to retain much of its catalytic activity, with a cleavage rate equal to 43% of the wt rate; see: Baidya, N.; Animons, G. E.; Matulic-Adamic, J.; Karpeisky, A. M.; Beigelman, L.; Uhlenbeck, O. C. RNA 1997, 3, 1135-1142.
37. Takagi, Y.; Ikeda, Y.; Taira, K. Top. Curr. Chem. 2004, 232, 213-251.
38. (a) Wang, S.; Karbstein, K.; Peracchi, A.; Beigelman, L.; Herschlag, D. Biochemistry 1999, 38, 14363-14378.
39. (b) Murray, J. B.; Scott, W. G. J. Mol. Biol. 2000, 296, 33-41.
40. Merget, M.; Günther, K.; Bernd, M.; Günther, E.; Tacke, R. J. Organomet. Chem. 2001, 628, 183-194 and references therein.
41. Although there are several examples of silicon-containing nucleosides, there are just two examples of germanium-containing nucleosides or nucleosidelike compounds, see: (a) Mel'nik, S. I.; Bakhmedova, A. A.; Nedorezova, T. P.; Iartseva, I. V.; Zhukova, O. S. Bioorg. Khim. 1985, 11, 1248-1252. (b) Lukevics, E.; Ignatovich, L.; Shilina, N.; Kemme, A.; Sjakste, N. Metal-Based Drugs 1994, 1, 65-72.
42. Although there are several examples of silicon-containing nucleosides, there are just two examples of germanium-containing nucleosides or nucleosidelike compounds, see: (a) Mel'nik, S. I.; Bakhmedova, A. A.; Nedorezova, T. P.; Iartseva, I. V.; Zhukova, O. S. Bioorg. Khim. 1985, 11, 1248-1252. (b) Lukevics, E.; Ignatovich, L.; Shilina, N.; Kemme, A.; Sjakste, N. Metal-Based Drugs 1994, 1, 65-72.